Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Published: November 2009

Open Access Gateway

Mucinous Cystadenocarcinoma of the Breast with Estrogen Receptor Expression: A Case Report and Review of the Literature

Rakıcı S.a · Gönüllü G.b · Gürsel Ş.B.c · Yıldız L.d · Bayrak İ.K.e · Yücel İ.b

Author affiliations

aDepartment of Radiation Oncology, Atatürk University Faculty of Medicine, Erzurum, Departments of bMedical Oncology, cRadiation Oncology, dPathology, and eRadiology, Ondokuz Mayıs University Faculty of Medicine, Samsun, Turkey

Corresponding Author

Dr. Sema Rakıcı

Department of Radiation Oncology

Atatürk University Faculty of Medicine

TR–25240 Erzurum (Turkey)

Tel. +90 50 5402 8302, Fax +90 44 2236 0988, E-Mail sema.neslihan@gmail.com

Related Articles for ""

Case Rep Oncol 2009;2:210–216

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


Primary mucinous cystadenocarcinoma (MCA) of the breast was first described by Koenig and Tavassoli in 1998. To our knowledge, only 9 cases of MCA of the breast have been reported. The optimal treatment of MCA could not be defined yet. This article aims to increase the knowledge about this rare variant of breast cancer and to review the literature.

© 2009 S. Karger AG, Basel

Article / Publication Details

First-Page Preview
Abstract of Published: November 2009

Published online: November 14, 2009
Issue release date: September – December

Number of Print Pages: 7
Number of Figures: 4
Number of Tables: 1

eISSN: 1662-6575 (Online)

For additional information: http://www.karger.com/CRO

Open Access License / Drug Dosage / Disclaimer

Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.